The Hague, Netherlands
The Hague, Netherlands

Time filter

Source Type

— The Global Algae Biofuel Market Research Report 2017 is a professional and in-depth study on the current state of the Algae Biofuel Market. This report studies Algae Biofuel in Global market, especially North America, Europe, China, Japan, Southeast Asia and India. focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer covering top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Algenol Biofuels, Royal Dutch Shell, Cellana, Solazyme, Solix BioSystems, Sapphire Energy, Seambiotic, Blue Marble Production, Diversified Technologies, Origin Oils, Proviron, Exxon Mobil, Synthetic Genomics, Qeshm Microalgae Biorefinery and Genifuels. Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Algae Biofuel in these regions, from 2017 to 2022 (forecast), like North America, Europe, China, Japan, Southeast Asia and India. Firstly, Algae Biofuel Market On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Biodiesel, Bioethanol and Others (Bio-butanol,Biogas, Hydrocarbons and Drop-in Fuels). On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales) , market share and growth rate of Algae Biofuel for each application, including Transportation Fuel, Industrial Use and Others. View more details about this report @ http://www.reportsweb.com/global-algae-biofuel-market-research-report-2017 Few points from Table of Contents 5 Global Algae Biofuel Production, Revenue (Value) , Price Trend by Type 5.1 Global Algae Biofuel Production and Market Share by Type (2012-2017) 5.2 Global Algae Biofuel Revenue and Market Share by Type (2012-2017) 5.3 Global Algae Biofuel Price by Type (2012-2017) 5.4 Global Algae Biofuel Production Growth by Type (2012-2017) 6 Global Algae Biofuel Market Analysis by Application 6.1 Global Algae Biofuel Consumption and Market Share by Application (2012-2017) 6.2 Global Algae Biofuel Consumption Growth Rate by Application (2012-2017) 6.3 Market Drivers and Opportunities 6.3.1 Potential Applications 6.3.2 Emerging Markets/Countries 7 Global Algae Biofuel Manufacturers Profiles/Analysis 7.1 Algenol Biofuels 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Algae Biofuel Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Algenol Biofuels Algae Biofuel Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.1.4 Main Business/Business Overview 7.2 Royal Dutch Shell 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Algae Biofuel Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 Royal Dutch Shell Algae Biofuel Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.2.4 Main Business/Business Overview 7.3 Cellana 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Algae Biofuel Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Cellana Algae Biofuel Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.3.4 Main Business/Business Overview For more information, please visit http://www.reportsweb.com/global-algae-biofuel-market-research-report-2017


Vault Pharma, an immunology-focused biotechnology company developing precision therapies for cancer and infectious diseases, named Michael J. Kamdar, Chief Executive Officer and Director at Molecular Assemblies Inc., and Todd N. Smith, Chief Executive Officer at Novum Pharma, to the company’s Board of Directors. “Mike and Todd add depth, experience and leadership to an already distinguished group of leaders on the Vault Pharma Board of Directors,” said Mr. Oliver Foellmer, President & CEO at Vault Pharma. “With Mike and Todd, Vault Pharma is in a stronger position to transition into and be successful in the commercial stages of our product development.” Vault Pharma is developing a unique therapeutics platform using the body’s own naturally occurring vault protein particles found abundantly in human cells to activate the immune system against cancer cells, bacteria and viruses. The vault particle was discovered by Vault Pharma Founder Dr. Leonard Rome, a Professor at the David Geffen School of Medicine at UCLA. As CEO at Molecular Assemblies, Mr. Kamdar leads the company that is developing a proprietary enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. Mr. Kamdar has accounted for deal transactions in excess of $1 billion and has raised more than $400 million from venture capital and public capital markets. Previously, Mr. Kamdar was President and Founder of VentiRx Pharmaceuticals, an immuno-oncology company focused on TLR8 agonists acquired by Celgene. Mr. Kamdar currently serves on the board of directors at Prime Genomics, Medipacs (Chairman) and Cellana. Mr. Smith has more than 20 years of pharmaceutical, medical device and biotechnology leadership experience. He has a reputation for building companies and leading them to commercial success and business development excellence. Mr. Smith has led high-performing commercial teams at Bayer, Abbott, Horizon Pharma, Agouron Pharmaceuticals and Fenwal, Inc. Mr. Smith currently is CEO at Novum Pharma, a global specialty pharmaceuticals company focused on providing innovative therapeutic solutions and ensuring treatment access for patients. Vault Pharma is expected to introduce its lead drug candidate, VPI-101, into Phase I clinical trials in 2017. A potential cancer immunotherapy treatment, VPI-101 has shown effectiveness in lung cancer, glioblastoma (brain tumors) and melanoma. VPI-101 successfully completed preclinical animal efficacy and active ingredient phase I safety trials. Vault Pharma, with headquarters in Los Angeles, Calif., is a leading immunology-focused biotechnology company developing and commercializing immunotherapy treatments for cancer and infectious diseases. Vault Pharma’s mission is to develop safe and effective immunotherapeutics that will transform existing treatment paradigms.


Kiron V.,University of Nordland | Phromkunthong W.,Prince of Songkla University | Huntley M.,University of Hawaii at Manoa | Huntley M.,Cellana B.V. | And 3 more authors.
Aquaculture Nutrition | Year: 2012

Two marine algal products MAP3 and MAP8 were examined for their suitability as fishmeal protein substitutes in feeds of three prominent farmed species, through short-term feeding studies. Algal meals were tested at 5 and 10% protein replacement levels for Atlantic salmon and at 25 and 40% for common carp and whiteleg shrimp. At the end of the 12-week period, the growth and feed performance of the two fish species did not reveal any significant difference between those fish offered the algae-based feed and those offered the control feed. The whole body proximate compositions of Atlantic salmon fed the control and algae-based feeds were not significantly different. In common carp, the lipid content in the fish fed higher level of MAP3 was significantly lower than that of the fish fed the control feed. In whiteleg shrimp, at the end of the 9-week feeding period, growth performance and feed utilization did not differ between the treatment groups. Protein content in the shrimp fed the higher level of MAP8 was significantly lower than that of shrimp on the control feed. The three species could accept the algal meals in their feeds at the tested levels, though there were some noticeable effects on body composition at higher inclusion levels. © 2012 Blackwell Publishing Ltd.


Ringuet S.,Duke University | Sassano L.,Duke University | Johnson Z.I.,Duke University | Johnson Z.I.,Cellana BV
Journal of Environmental Monitoring | Year: 2011

A sensitive, accurate and rapid analysis of major nutrients in aquatic systems is essential for monitoring and maintaining healthy aquatic environments. In particular, monitoring ammonium (NH4+) concentrations is necessary for maintenance of many fish stocks, while accurate monitoring and regulation of ammonium, orthophosphate (PO4 3-), silicate (Si(OH)4) and nitrate (NO3 -) concentrations are required for regulating algae production. Monitoring of wastewater streams is also required for many aquaculture, municipal and industrial wastewater facilities to comply with local, state or federal water quality effluent regulations. Traditional methods for quantifying these nutrient concentrations often require laborious techniques or expensive specialized equipment making these analyses difficult. Here we present four alternative microcolorimetric assays that are based on a standard 96-well microplate format and microplate reader that simplify the quantification of each of these nutrients. Each method uses small sample volumes (200 L), has a detection limit ≤1 M in freshwater and ≤2 M in saltwater, precision of at least 8% and compares favorably with standard analytical procedures. Routine use of these techniques in the laboratory and at an aquaculture facility to monitor nutrient concentrations associated with microalgae growth demonstrates that they are rapid, accurate and highly reproducible among different users. These techniques offer an alternative to standard nutrient analyses and because they are based on the standard 96-well format, they significantly decrease the cost and time of processing while maintaining high precision and sensitivity. © The Royal Society of Chemistry 2011.


SAN DIEGO and KAILUA-KONA, Hawaii, Nov. 3, 2016 /PRNewswire/ -- Cellana, Inc., a leading developer of algae-based products for sustainable nutrition and energy applications, and PIVEG, Inc., a leader in high-specification ingredients for the nutraceutical, pharmaceutical, agricultural,...


News Article | December 18, 2015
Site: www.greencarcongress.com

« Volkswagen of America retains Ken Feinberg to design and administer claims program for TDI emissions compliance issue | Main | San Francisco switches city fleet to Neste NEXBTL renewable diesel » Sandia National Laboratories and Arizona State University (ASU) have teamed up to improve computational models of algae growth in raceway ponds that can predict performance, improve pond design and operation and discover ways to improve algae yield outdoors. In addition, Sandia and ASU will further develop spectro-radiometric techniques to monitor optically the growth and health of algae pond cultivation in real-time and to detect early warnings of predators and pathogens in outdoor algal ponds. The work is part of a newly signed Cooperative Research and Development Agreement (CRADA) between ASU and Sandia to collaborate on algae-based biofuels, solar fuels, concentrating solar technologies, photovoltaics, electric grid modernization and the energy-water nexus. The umbrella CRADA also covers international applications of the technologies and science and engineering education. The topics were first identified in a 2013 memo of understanding between Sandia and ASU focusing on collaborations to support science, technology, engineering and mathematics (STEM) fields. This is the first CRADA Sandia has executed with a university in nearly 15 years and is currently the only active umbrella CRADA with an institution of higher education. The algae cultivation modeling and monitoring projects are the first two efforts funded under this umbrella CRADA. Sandia researcher Ron Pate said Sandia brings distinctive capabilities for physics-based modeling of algae cultivation systems performance and for remote spectroradiometric monitoring and diagnostics of algae growth and state of health, while ASU has a variety of algae species under cultivation in outdoor ponds in a range of scales in which to take measurements. Pate serves as deputy director for ATP3 (Algae Testbed Public-Private Partnership), overseeing Sandia technical tasks under the project. The ATP3 project was established to support the algae research and development community and industry to advance the field and to help accelerate progress toward more rapid and successful commercialization of algae-based technologies for fuels and products. ATP3 is funded by the DOE’s Energy Efficiency and Renewable Energy Bioenergy Technologies Office. ATP3 partners include Sandia; ASU; the National Renewable Energy Laboratory; California Polytechnic State University in San Luis Obispo; the Georgia Institute of Technology in Atlanta; and the algae companies San Diego-based Cellana Inc. with algae cultivation facilities in Kona, Hawaii; Commercial Algae Management in Franklin, North Carolina; and Florida Algae in Vero Beach, Florida. Two projects will exercise the new Sandia/ASU CRADA: Algal Cultivation Growth Dynamic Modeling and Analysis focuses on the further development of a Sandia algae growth model based on the effect of light, temperature, nutrients, pH and salinity integrated into an open raceway pond hydrodynamic computational fluid dynamics model. The algae growth model has been partially validated utilizing multiple data sets from partners involved in ATP3. Under the CRADA, the modeling will be further refined through improvement of the paddlewheel-driven pond circulation flow and mixing portion of the model based on the application of hydrodynamic measurement data taken from experimental testing with progressively larger scale outdoor ponds operated by ATP3 partners. The 12-month project, led by principal investigators Patricia Gharagozloo from Sandia and John McGowen from ASU, will be conducted in two phases. The first phase will study the flow dynamics of turbulence models and control parameters in open raceway ponds, which are currently the most promising outdoor cultivation system approach for cost-effectively growing algae at the large scales required for producing fuels. In this phase, ASU will measure the spatial variations in velocity of the flow of algae-water mix in the ponds at various paddlewheel speeds. The second phase will calibrate the model and verify the appropriate turbulence physics to be accounted for at certain scales of ponds for one paddlewheel speed. After the two phases, a study will be conducted to compare the data with model results at additional paddlewheel speeds. Algal Predator and Pathogen Signature Verification looks at exploring and exploiting the various detailed optical signatures that arise when the algae cultivation pond surface is monitored using Sandia’s optical spectro-radiometric techniques. These techniques can differentiate algae growth and state of health and provide an early warning of the active presence of predators and pathogens in outdoor algal ponds. Sandia researcher Jerilyn Timlin and McGowen are the principal investigators for this project. Sandia researcher Tom Reichardt, who pioneered the original technology as part of a bioscience Laboratory Directed Research & Development project, also serves as technical contributor to the project. During the first phase of this project, controlled experiments will be conducted in the laboratory with a host-pathogen-predator pair that the team has seen cause problems in the field in order to understand the parameters that control culture collapse and identify spectral markers that indicate the presence of the pathogen or predator. The second phase will consist of experiments in the field to determine how well the identified spectral markers predict the presence of the pathogen or predator in the challenges of an outdoor environment.


News Article | November 30, 2016
Site: www.newsmaker.com.au

This report studies DHA from Algae in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top DHA from Algae Players in each region, with sales, price, revenue and market share for top manufacturer, covering DSM Lonza Cellana JC Biotech FEMICO Runke Bioco CABIO Fuxing Huison Kingdomway Amry Yuexiang Keyuan Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top 5 players in these regions, from 2012 to 2017 (forecast), like North America (United States, Canada and Mexico) Asia-Pacific (China, Japan, Southeast Asia, India and Korea) Europe (Germany, UK, France, Italy and Russia etc. South America (Brazil, Chile, Peru and Argentina) Middle East and Africa (Egypt, South Africa, Saudi Arabia) Split by Product Types, with sales, revenue, price, market share of each type, can be divided into DHA powder DHA oil Split by applications, this report focuses on sales, market share and growth rate of DHA from Algae in each application, can be divided into -Infant Formula -Nutritional Supplements -Food & Beverage 2017 Top 5 DHA from Algae Manufacturers/Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa 1 DHA from Algae Market Overview 1.1 Product Overview and Scope of DHA from Algae 1.2 DHA from Algae Segment by Types 1.2.1 Global Sales Market Share of DHA from Algae by Types in 2015 1.2.2 DHA powder 1.2.3 DHA oil 1.3 DHA from Algae Segment by Applications 1.3.1 DHA from Algae Consumption Market Share by Applications in 2015 1.3.2 -Infant Formula 1.3.3 -Nutritional Supplements 1.3.4 -Food & Beverage 1.4 DHA from Algae Market by Regions 1.4.1 North America Status and Prospect (2012-2022) 1.4.2 Asia-Pacific Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 South America Status and Prospect (2012-2022) 1.4.5 Middle East and Africa Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of DHA from Algae (2012-2022) 2 Global DHA from Algae Sales, Revenue (value) and Market Share by Players 2.1 Global DHA from Algae Sales and Market Share in 2015 and 2016 by Players 2.2 Global DHA from Algae Revenue and Market Share by Players in 2015 and 2016 2.3 Global DHA from Algae Average Price by Players in 2015 and 2016 2.4 Global DHA from Algae Manufacturing Base Distribution, Sales Area, Product Types by Players 2.5 DHA from Algae Market Competitive Situation and Trends 2.5.1 DHA from Algae Market Concentration Rate 2.5.2 DHA from Algae Market Share of Top 3 and Top 5 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Global DHA from Algae Sales, Revenue (Value) by Regions, Type and Application (2012-2017) 3.1 Global DHA from Algae Sales, Revenue and Market Share by Regions (2012-2017) 3.1.1 Global DHA from Algae Sales and Market Share by Regions (2012-2017) 3.1.2 Global DHA from Algae Revenue and Market Share by Regions (2012-2017) 3.2 Global DHA from Algae Sales, Revenue, Market Share and Price by Type (2012-2017) 3.2.1 Global DHA from Algae Sales and Market Share by Type (2012-2017) 3.2.2 Global DHA from Algae Revenue and Market Share by Type (2012-2017) 3.2.3 Global DHA from Algae Price by Type (2012-2017) 3.3 Global DHA from Algae Sales and Market Share by Application (2012-2017) 3.4 Global DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4 North America Top 5 Players DHA from Algae Sales, Revenue and Price 4.1 North America Top 5 Players DHA from Algae Sales, Revenue and Market Share in 2015 and 2016 4.1.1 North America Top 5 Players DHA from Algae Sales and Market Share in 2015 and 2016 4.1.2 North America Top 5 Players DHA from Algae Revenue and Market Share in 2015 and 2016 4.2 North America DHA from Algae Sales, Revenue, Market Share and Price by Type (2012-2017) 4.2.1 North America DHA from Algae Sales and Market Share by Type (2012-2017) 4.2.2 North America DHA from Algae Revenue and Market Share by Type (2012-2017) 4.2.3 North America DHA from Algae Price by Type (2012-2017) 4.3 North America DHA from Algae Sales and Market Share by Application (2012-2017) 4.4 North America DHA from Algae Sales and Market Share by Country (US, Canada and Mexico) (2012-2017) 4.5 North America DHA from Algae Import & Export (2012-2017) 5 Europe Top 5 Players DHA from Algae Sales, Revenue and Price 5.1 Europe Top 5 Players DHA from Algae Sales, Revenue and Market Share in 2015 and 2016 5.1.1 Europe Top 5 Players DHA from Algae Sales and Market Share in 2015 and 2016 5.1.2 Europe Top 5 Players DHA from Algae Revenue and Market Share in 2015 and 2016 5.2 Europe DHA from Algae Sales, Revenue, Market Share and Price by Type (2012-2017) 5.2.1 Europe DHA from Algae Sales and Market Share by Type (2012-2017) 5.2.2 Europe DHA from Algae Revenue and Market Share by Type (2012-2017) 5.2.3 Europe DHA from Algae Price by Type (2012-2017) 5.3 Europe DHA from Algae Sales and Market Share by Application (2012-2017) 5.4 Europe DHA from Algae Sales and Market Share by Country (Germany, UK, France, Italy and Russia) (2012-2017) 5.5 Europe DHA from Algae Import & Export (2012-2017) 6 Asia-Pacific Top 5 Players DHA from Algae Sales, Revenue and Price 6.1 Asia-Pacific Top 5 Players DHA from Algae Sales, Revenue and Market Share in 2015 and 2016 6.1.1 Asia-Pacific Top 5 Players DHA from Algae Sales and Market Share in 2015 and 2016 6.1.2 Asia-Pacific Top 5 Players DHA from Algae Revenue and Market Share in 2015 and 2016 6.2 Asia-Pacific DHA from Algae Sales, Revenue, Market Share and Price by Type (2012-2017) 6.2.1 Asia-Pacific DHA from Algae Sales and Market Share by Type (2012-2017) 6.2.2 Asia-Pacific DHA from Algae Revenue and Market Share by Type (2012-2017) 6.2.3 Asia-Pacific DHA from Algae Price by Type (2012-2017) 6.3 Asia-Pacific DHA from Algae Sales and Market Share by Application (2012-2017) 6.4 Asia-Pacific DHA from Algae Sales and Market Share by Country (China, Japan, Southeast Asia, India and Korea) (2012-2017) 6.5 Asia-Pacific DHA from Algae Import & Export (2012-2017) 7 South America Top 5 Players DHA from Algae Sales, Revenue and Price 7.1 South America Top 5 Players DHA from Algae Sales, Revenue and Market Share in 2015 and 2016 7.1.1 South America Top 5 Players DHA from Algae Sales and Market Share in 2015 and 2016 7.1.2 South America Top 5 Players DHA from Algae Revenue and Market Share in 2015 and 2016 7.2 South America DHA from Algae Sales, Revenue, Market Share and Price by Type (2012-2017) 7.2.1 South America DHA from Algae Sales and Market Share by Type (2012-2017) 7.2.2 South America DHA from Algae Revenue and Market Share by Type (2012-2017) 7.2.3 South America DHA from Algae Price by Type (2012-2017) 7.3 South America DHA from Algae Sales and Market Share by Application (2012-2017) 7.4 South America DHA from Algae Sales and Market Share by Country (Brazil, Argentina, Chile and Peru) (2012-2017) 7.5 South America DHA from Algae Import & Export (2012-2017) 8 Middle East & Africa Top 5 Players DHA from Algae Sales, Revenue and Price 8.1 Middle East & Africa Top 5 Players DHA from Algae Sales, Revenue and Market Share in 2015 and 2016 8.1.1 Middle East & Africa Top 5 Players DHA from Algae Sales and Market Share in 2015 and 2016 8.1.2 Middle East & Africa Top 5 Players DHA from Algae Revenue and Market Share in 2015 and 2016 8.2 Middle East & Africa DHA from Algae Sales, Revenue, Market Share and Price by Type (2012-2017) 8.2.1 Middle East & Africa DHA from Algae Sales and Market Share by Type (2012-2017) 8.2.2 Middle East & Africa DHA from Algae Revenue and Market Share by Type (2012-2017) 8.2.3 Middle East & Africa DHA from Algae Price by Type (2012-2017) 8.3 Middle East & Africa DHA from Algae Sales and Market Share by Application (2012-2017) 8.4 Middle East & Africa DHA from Algae Sales and Market Share by Country (Egypt, Saudi Arabia, South Africa and Iran) (2012-2017) 8.5 Middle East & Africa DHA from Algae Import & Export (2012-2017) 9 Global DHA from Algae Players Profiles/Analysis 9.1 DSM 9.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.1.2 DHA from Algae Product Types, Application and Specification 9.1.2.1 Type 1 9.1.2.2 Type 2 9.1.3 DSM DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.1.4 Main Business/Business Overview 9.2 Lonza 9.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.2.2 DHA from Algae Product Types, Application and Specification 9.2.2.1 Type 1 9.2.2.2 Type 2 9.2.3 Lonza DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.2.4 Main Business/Business Overview 9.3 Cellana 9.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.3.2 DHA from Algae Product Types, Application and Specification 9.3.2.1 Type 1 9.3.2.2 Type 2 9.3.3 Cellana DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.3.4 Main Business/Business Overview 9.4 JC Biotech 9.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.4.2 DHA from Algae Product Types, Application and Specification 9.4.2.1 Type 1 9.4.2.2 Type 2 9.4.3 JC Biotech DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.4.4 Main Business/Business Overview 9.5 FEMICO 9.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.5.2 DHA from Algae Product Types, Application and Specification 9.5.2.1 Type 1 9.5.2.2 Type 2 9.5.3 FEMICO DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.5.4 Main Business/Business Overview 9.6 Runke 9.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.6.2 DHA from Algae Product Types, Application and Specification 9.6.2.1 Type 1 9.6.2.2 Type 2 9.6.3 Runke DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.6.4 Main Business/Business Overview 9.7 Bioco 9.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.7.2 DHA from Algae Product Types, Application and Specification 9.7.2.1 Type 1 9.7.2.2 Type 2 9.7.3 Bioco DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.7.4 Main Business/Business Overview 9.8 CABIO 9.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.8.2 DHA from Algae Product Types, Application and Specification 9.8.2.1 Type 1 9.8.2.2 Type 2 9.8.3 CABIO DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.8.4 Main Business/Business Overview 9.9 Fuxing 9.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.9.2 DHA from Algae Product Types, Application and Specification 9.9.2.1 Type 1 9.9.2.2 Type 2 9.9.3 Fuxing DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.9.4 Main Business/Business Overview 9.10 Huison 9.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.10.2 DHA from Algae Product Types, Application and Specification 9.10.2.1 Type 1 9.10.2.2 Type 2 9.10.3 Huison DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.10.4 Main Business/Business Overview 9.11 Kingdomway 9.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.11.2 DHA from Algae Product Types, Application and Specification 9.11.2.1 Type 1 9.11.2.2 Type 2 9.11.3 Kingdomway DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.11.4 Main Business/Business Overview 9.12 Amry 9.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.12.2 DHA from Algae Product Types, Application and Specification 9.12.2.1 Type 1 9.12.2.2 Type 2 9.12.3 Amry DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.12.4 Main Business/Business Overview 9.13 Yuexiang 9.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.13.2 DHA from Algae Product Types, Application and Specification 9.13.2.1 Type 1 9.13.2.2 Type 2 9.13.3 Yuexiang DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.13.4 Main Business/Business Overview 9.14 Keyuan 9.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.14.2 DHA from Algae Product Types, Application and Specification 9.14.2.1 Type 1 9.14.2.2 Type 2 9.14.3 Keyuan DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 9.14.4 Main Business/Business Overview Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=789104


News Article | December 2, 2016
Site: www.newsmaker.com.au

This report studies DHA from Algae in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturers in each country, covering DSM Lonza Cellana JC Biotech FEMICO Runke Bioco CABIO Fuxing Huison Kingdomway Amry Yuexiang Keyuan Market Segment by Countries, this report splits Global into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 (forecast), like 1 United States 2 Canada 3 Mexico 4 Germany 5 France 6 UK 7 Italy 8 Russia 9 China 10 Japan 11 India 12 Korea 13 Southeast Asia 14 Australia 15 Brazil 16 Middle East 17 Africa Split by Product Types, with sales, revenue, price, market share of each type, can be divided into DHA powder DHA oil Split by applications, this report focuses on sales, market share and growth rate of DHA from Algae in each application, can be divided into -Infant Formula -Nutritional Supplements -Food & Beverage 1 DHA from Algae Market Overview 1.1 Product Overview and Scope of DHA from Algae 1.2 DHA from Algae Segment by Types 1.2.1 Global Sales Market Share of DHA from Algae by Types in 2015 1.2.2 DHA powder 1.2.3 DHA oil 1.3 DHA from Algae Segment by Applications 1.3.1 DHA from Algae Consumption Market Share by Applications in 2015 1.3.2 -Infant Formula 1.3.3 -Nutritional Supplements 1.3.4 -Food & Beverage 1.4 DHA from Algae Market by Countries 1.4.1 United States Status and Prospect (2012-2022) 1.4.2 Canada Status and Prospect (2012-2022) 1.4.3 Germany Status and Prospect (2012-2022) 1.4.4 France Status and Prospect (2012-2022) 1.4.5 UK Status and Prospect (2012-2022) 1.4.6 Italy Status and Prospect (2012-2022) 1.4.7 Russia Status and Prospect (2012-2022) 1.4.8 China Status and Prospect (2012-2022) 1.4.9 Japan Status and Prospect (2012-2022) 1.4.10 India Status and Prospect (2012-2022) 1.4.11 Korea Status and Prospect (2012-2022) 1.4.12 Southeast Asia Status and Prospect (2012-2022) 1.4.13 Australia Status and Prospect (2012-2022) 1.4.14 Brazil Status and Prospect (2012-2022) 1.4.15 Mexico Status and Prospect (2012-2022) 1.4.16 Middle East Status and Prospect (2012-2022) 1.4.17 Africa Status and Prospect (2012-2022) 1.5 Global DHA from Algae Overview and Market Size (Value) (2012-2022) 1.5.1 Global Market DHA from Algae Overview 1.5.2 Global Market DHA from Algae Revenue (Million USD) and Growth Rate (2012-2022) 2 Global DHA from Algae Sales, Revenue (Value) and Market Share by Manufacturers 2.1 Global DHA from Algae Sales and Market Share in 2015 and 2016 by Manufacturers 2.2 Global DHA from Algae Revenue and Market Share by Manufacturers in 2015 and 2016 2.3 Global DHA from Algae Average Price by Manufacturers in 2015 and 2016 2.4 Global DHA from Algae Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers 2.5 DHA from Algae Market Competitive Situation and Trends 2.5.1 DHA from Algae Market Concentration Rate 2.5.2 DHA from Algae Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global DHA from Algae Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 3.1 Global DHA from Algae Sales, Revenue and Market Share by Countries (2012-2017) 3.1.1 Global DHA from Algae Sales and Market Share by Countries (2012-2017) 3.1.2 Global DHA from Algae Revenue and Market Share by Countries (2012-2017) 3.1.3 Global DHA from Algae Price by Countries (2012-2017) 3.2 Global DHA from Algae Sales, Revenue, Market Share and Price by Type (2012-2017) 3.2.1 Global DHA from Algae Sales and Market Share by Type (2012-2017) 3.2.2 Global DHA from Algae Revenue and Market Share by Type (2012-2017) 3.2.3 Global DHA from Algae Price by Type (2012-2017) 3.3 Global DHA from Algae Sales and Market Share by Application (2012-2017) 3.4 Global Market DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4 Global DHA from Algae Manufacturers Profiles/Analysis 4.1 DSM 4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.1.2 DHA from Algae Product Types, Application and Specification 4.1.2.1 Type 1 4.1.2.2 Type 2 4.1.3 DSM DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.1.4 Main Business/Business Overview 4.2 Lonza 4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.2.2 DHA from Algae Product Types, Application and Specification 4.2.2.1 Type 1 4.2.2.2 Type 2 4.2.3 Lonza DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.2.4 Main Business/Business Overview 4.3 Cellana 4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.3.2 DHA from Algae Product Types, Application and Specification 4.3.2.1 Type 1 4.3.2.2 Type 2 4.3.3 Cellana DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.3.4 Main Business/Business Overview 4.4 JC Biotech 4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.4.2 DHA from Algae Product Types, Application and Specification 4.4.2.1 Type 1 4.4.2.2 Type 2 4.4.3 JC Biotech DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.4.4 Main Business/Business Overview 4.5 FEMICO 4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.5.2 DHA from Algae Product Types, Application and Specification 4.5.2.1 Type 1 4.5.2.2 Type 2 4.5.3 FEMICO DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.5.4 Main Business/Business Overview 4.6 Runke 4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.6.2 DHA from Algae Product Types, Application and Specification 4.6.2.1 Type 1 4.6.2.2 Type 2 4.6.3 Runke DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.6.4 Main Business/Business Overview 4.7 Bioco 4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.7.2 DHA from Algae Product Types, Application and Specification 4.7.2.1 Type 1 4.7.2.2 Type 2 4.7.3 Bioco DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.7.4 Main Business/Business Overview 4.8 CABIO 4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.8.2 DHA from Algae Product Types, Application and Specification 4.8.2.1 Type 1 4.8.2.2 Type 2 4.8.3 CABIO DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.8.4 Main Business/Business Overview 4.9 Fuxing 4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.9.2 DHA from Algae Product Types, Application and Specification 4.9.2.1 Type 1 4.9.2.2 Type 2 4.9.3 Fuxing DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.9.4 Main Business/Business Overview 4.10 Huison 4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.10.2 DHA from Algae Product Types, Application and Specification 4.10.2.1 Type 1 4.10.2.2 Type 2 4.10.3 Huison DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.10.4 Main Business/Business Overview 4.11 Kingdomway 4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.11.2 DHA from Algae Product Types, Application and Specification 4.11.2.1 Type 1 4.11.2.2 Type 2 4.11.3 Kingdomway DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.11.4 Main Business/Business Overview 4.12 Amry 4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.12.2 DHA from Algae Product Types, Application and Specification 4.12.2.1 Type 1 4.12.2.2 Type 2 4.12.3 Amry DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.12.4 Main Business/Business Overview 4.13 Yuexiang 4.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.13.2 DHA from Algae Product Types, Application and Specification 4.13.2.1 Type 1 4.13.2.2 Type 2 4.13.3 Yuexiang DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.13.4 Main Business/Business Overview 4.14 Keyuan 4.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.14.2 DHA from Algae Product Types, Application and Specification 4.14.2.1 Type 1 4.14.2.2 Type 2 4.14.3 Keyuan DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 4.14.4 Main Business/Business Overview 5 North America DHA from Algae Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 5.1 North America DHA from Algae Sales, Revenue and Market Share by Countries (2012-2017) 5.1.1 North America DHA from Algae Sales and Market Share by Countries (2012-2017) 5.1.2 North America DHA from Algae Revenue and Market Share by Countries (2012-2017) 5.1.3 North America DHA from Algae Price by Countries (2012-2017) 5.1.4 North America Market DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 5.1.5 North America DHA from Algae Import & Export (2012-2017) 5.2 United States DHA from Algae Sales, Revenue and Growth, by Type and Application (2012-2017) 5.2.1 United States DHA from Algae Sales, Revenue and Growth Rate (2012-2017) 5.2.2 United States DHA from Algae Sales and Market Share by Type (2012-2017) 5.2.3 United States DHA from Algae Revenue and Market Share by Type (2012-2017) 5.2.4 United States DHA from Algae Price by Type (2012-2017) 5.2.5 United States DHA from Algae Sales and Market Share by Application (2012-2017) 5.3 Canada DHA from Algae Sales, Revenue and Growth, by Type and Application (2012-2017) 5.3.1 Canada DHA from Algae Sales, Revenue and Growth Rate (2012-2017) 5.3.2 Canada DHA from Algae Sales and Market Share by Type (2012-2017) 5.3.3 Canada DHA from Algae Revenue and Market Share by Type (2012-2017) 5.3.4 Canada DHA from Algae Price by Type (2012-2017) 5.3.5 Canada DHA from Algae Sales and Market Share by Application (2012-2017) 6 Latin America DHA from Algae Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 6.1 Latin America DHA from Algae Sales, Revenue and Market Share by Countries (2012-2017) 6.1.1 Latin America DHA from Algae Sales and Market Share by Countries (2012-2017) 6.1.2 Latin America DHA from Algae Revenue and Market Share by Countries (2012-2017) 6.1.3 Latin America DHA from Algae Price by Countries (2012-2017) 6.1.4 Latin America Market DHA from Algae Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.5 Latin America DHA from Algae Import & Export (2012-2017) 6.2 Mexico DHA from Algae Sales, Revenue and Growth, by Type and Application (2012-2017) 6.2.1 Mexico DHA from Algae Sales, Revenue and Growth Rate (2012-2017) 6.2.2 Mexico DHA from Algae Sales and Market Share by Type (2012-2017) 6.2.3 Mexico DHA from Algae Revenue and Market Share by Type (2012-2017) 6.2.4 Mexico DHA from Algae Price by Type (2012-2017) 6.2.5 Mexico DHA from Algae Sales and Market Share by Application (2012-2017) 6.3 Brazil DHA from Algae Sales, Revenue and Growth, by Type and Application (2012-2017) 6.3.1 Brazil DHA from Algae Sales, Revenue and Growth Rate (2012-2017) 6.3.2 Brazil DHA from Algae Sales and Market Share by Type (2012-2017) 6.3.3 Brazil DHA from Algae Revenue and Market Share by Type (2012-2017) 6.3.4 Brazil DHA from Algae Price by Type (2012-2017) 6.3.5 Brazil DHA from Algae Sales and Market Share by Application (2012-2017) Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=789124

Loading Cellana BV collaborators
Loading Cellana BV collaborators